BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8399893)

  • 1. Onset of life-threatening ventriculitis during ceftazidime therapy for nosocomial pneumonia due to Enterobacter cloacae.
    Land G; Salgado J; Greenberg RN
    Clin Infect Dis; 1993 Aug; 17(2):295-6. PubMed ID: 8399893
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ciprofloxacin in an infant with ventriculitis.
    Goepp JG; Lee CK; Anderson T; Dick JD; Stokoe JM; Eiden J
    J Pediatr; 1992 Aug; 121(2):303-5. PubMed ID: 1640304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection.
    Rapp RP; Billeter M; Hatton J; Young AB; Tibbs PA; Dempsey RJ
    Clin Pharm; 1991 Jan; 10(1):49-55. PubMed ID: 1999086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.
    Barnes BJ; Wiederhold NP; Micek ST; Polish LB; Ritchie DJ
    Pharmacotherapy; 2003 Apr; 23(4):537-42. PubMed ID: 12680484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia.
    Mangi RJ; Ryan J; Berenson C; Greco T; Simms M; Thornton G; Andriole VT
    Am J Med; 1988 Jul; 85(1A):44-8. PubMed ID: 3041818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
    Cascio A; Mezzatesta ML; Odierna A; Di Bernardo F; Barberi G; Iaria C; Stefani S; Giordano S
    Int J Infect Dis; 2014 Mar; 20():66-7. PubMed ID: 24412601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
    Czerwionka-Szaflarska M; Sobkowiak E
    Pediatr Pol; 1996 Jul; 71(7):605-7. PubMed ID: 8803464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrobacter diversus ventriculitis and brain abscesses in an adult.
    Booth LV; Palmer JD; Pateman J; Tuck AC
    J Infect; 1993 Mar; 26(2):207-9. PubMed ID: 8473769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
    Honderlick P; Saheb F; Cahen P
    Pathol Biol (Paris); 1999 May; 47(5):437-9. PubMed ID: 10418014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple beta-lactam resistance in Enterobacter cloacae following ceftazidime monotherapy.
    Black AS; Cohen J
    Lancet; 1985 Aug; 2(8450):331-2. PubMed ID: 2862496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nosocomial infections with resistant Enterobacter cloacae. Effects on the disease and the treatment].
    Olafsen K; Hotvedt R; Andersen BM; Almdahl SM; Sørlie D
    Tidsskr Nor Laegeforen; 1989 Jan; 109(3):332-6. PubMed ID: 2916217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased incidence of Enterobacter cloacae in a cardiovascular ward.
    Kanemitsu K; Endo S; Oda K; Saito K; Kunishima H; Hatta M; Inden K; Kaku M
    J Hosp Infect; 2007 Jun; 66(2):130-4. PubMed ID: 17512633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I integron-borne bla(VIM-1) carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia.
    Perilli M; Mezzatesta ML; Falcone M; Pellegrini C; Amicosante G; Venditti M; Stefani S
    Microb Drug Resist; 2008 Mar; 14(1):45-7. PubMed ID: 18321204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDM-1 encoded by a pNDM-HN380-like plasmid pNDM-BJ03 in clinical Enterobacter cloacae.
    Lü Y; Liu W; Liang H; Zhao S; Zhang W; Liu J; Jin C; Hu H
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):153-155. PubMed ID: 29195767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial septicaemia due to Enterobacter cloacae.
    Commun Dis Rep CDR Wkly; 1994 Apr; 4(17):77. PubMed ID: 7516785
    [No Abstract]   [Full Text] [Related]  

  • 18. Nontraumatic pneumocephalus due to nosocomial Enterobacter cloacae infection.
    Kuo CC; Wang JY; Chien JY; Chen YF; Wu VC; Tsai CW; Hwang JJ
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):108-10. PubMed ID: 19442474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections.
    Bassetti D; Cruciani M; Solbiati M; Rubini F; Gandola L; Valenti G; De Palma M; Corda R; Carimeo N
    Chemotherapy; 1991; 37(5):371-5. PubMed ID: 1804598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
    Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O
    J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.